Clinical Trial Update: Bevacizumab, Cetuximab, and Cisplatin With IMRT (Intensity-Modulated Radiation Therapy) for Patients With Stage III/IV Head and Neck Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of bevacizumab, cetuximab, and cisplatin with intensity-modulated radiation therapy for stage III/IV head and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Avastin (bevacizumab)
• CISPLATIN (cisplatin)
• ERBITUX (cetuximab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED